Skip to main content

Table 2 Demographics and clinical characteristics of healthy control, genetic high risk, and schizophrenia in cross-sectional study

From: Neurodevelopmental trajectories, polygenic risk, and lipometabolism in vulnerability and resilience to schizophrenia

 

Healthy Control

Genetic High Risk

Schizophrenia

F/χ2 Values

P Values

(n = 145)

(n = 75)

(n = 78)

Demographic characteristic

 Age at scans (year)

28.28 (7.83)

25.29 (8.24)

23.09 (8.23)

11.18

 < 0.001

 Gender (male/female)

58/87

43/32

22/56

13.57

0.001

 BMI

22.19 (3.63)

22.69 (4.11)

23.39 (4.33)

2.28

0.104

Clinical characteristic

 Duration of illness (months)

N/A

N/A

25.05 (40.70)

  

 First episode (yes/no)

N/A

N/A

55/23

  

 Medication (yes/no)

N/A

N/A

66/12

  

 BPRS

n = 131

n = 72

n = 77

  

18.44 (1.03)

18.93 (2.06)

31.73 (10.92)

140.07

 < 0.001

  1. Data are presented as mean (standard deviation)
  2. BMI Body mass index, BPRS Brief Psychiatric Rating Scale